The fee for D. Pharma at Mohammad Ali Jauhar University is 140000 INR. D. Pharma admission 2024 at Mohammad Ali Jauhar University will be based on NEET, JEECUP.
Duration | Fees |
Year 1 | 70000 INR |
Year 2 | 70000 INR |
Total Fees | 140000 INR |
Course name | D. Pharma |
Duration | 2 Years |
Course level | Diploma |
Mode of Study | Regular |
Total Fees | 140000 INR |
The eligibility criteria for the Diploma in Pharmacy degree at Mohammad Ali Jauhar University in India require candidates to have completed their 10+2 education with science subjects (Physics, Chemistry, and Biology) from a recognized board. Additionally, candidates must have secured a minimum aggregate score of 45% in the qualifying examination. Furthermore, it is essential for applicants to have studied English as one of the subjects in their 10+2 education. Meeting these criteria ensures that students possess the necessary foundation in science and English to pursue the Diploma in Pharmacy program at Mohammad Ali Jauhar University.
Here is a table highlighting important dates related to the exams accepted by Mohammad Ali Jauhar University for admission to D Pharma Pharmacy.
NEET Important DatesEvent Name | Date |
Official Notification Date | 01 Feb 2025 - 01 Feb 2025 (TENTATIVE) |
Registration Date | 01 Feb 2025 - 01 Apr 2025 (TENTATIVE) |
Admit Card Date | 01 May 2025 - 01 May 2025 (TENTATIVE) |
Exam Date | 04 May 2025 - 04 May 2025 (TENTATIVE) |
Answer Key Release Date | 01 Jun 2025 - 01 Jun 2025 (TENTATIVE) |
Result Date | 12 Jun 2025 - 12 Jun 2025 (TENTATIVE) |
Counselling Date | 01 Aug 2025 - 01 Aug 2025 (TENTATIVE) |
Event Name | Date |
Official Notification Date | 01 Jan 2025 - 01 Jan 2025 (TENTATIVE) |
Registration Date | 01 Jan 2025 - 01 Feb 2025 (TENTATIVE) |
Admit Card Date | 01 Mar 2025 - 01 Mar 2025 (TENTATIVE) |
Exam Date | 01 Mar 2025 - 01 Mar 2025 (TENTATIVE) |
Answer Key Release Date | 01 Mar 2025 - 01 Mar 2025 (TENTATIVE) |
Result Date | 01 Apr 2025 - 01 Apr 2025 (TENTATIVE) |
Counselling Date | 01 Jul 2025 - 01 Jul 2025 (TENTATIVE) |